ARCHIVES

NCI Told It Needs Overview Of Basic Research For Visibility And To Pursue Breakthroughs

This article is from The Cancer Letter archive.

Vol. 04 No. 28 | July 14, 1978

Download PDF Visit The Full Archive

Related Articles

ASCO: NCI Director Should Be A Clinician; NBCC Endorses Mary-Claire King

March 10, 1995

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers

August 2, 1996

Upton Promises “Minimal Disruption” As Result of Changes; Centers Program Probably To Move

January 20, 1978

NCAB Okays Concepts For ICI Contract Support, Databases

October 11, 1991

Adcetris Granted Approval For Hodgkin’s Lymphoma and ALCL

September 30, 2011